Incorporating MDMA as an Adjunct in Emotionally Focused Couples Therapy With Clients Impacted by Trauma or PTSD
The Family Journal July 1, 2019 Peer reviewed DOI: 10.1177/1066480719852360
Summary
MDMA may be beneficial when used alongside emotionally focused couples therapy (EFT) for clients with PTSD, particularly those who have experienced trauma. The U.S. FDA has recognized MDMA as a 'breakthrough therapy' for PTSD and approved a Phase 3 clinical trial. This article seeks to combine existing research on MDMA-assisted psychotherapy with the evidence-based methods of EFT to enhance treatment outcomes.
Study at a glance
| Population | clients in emotionally focused couples therapy with PTSD symptoms |
|---|---|
| Key finding | MDMA is explored as an adjunct to emotionally focused couples therapy for treating PTSD. |
Abstract
This article explores incorporating 3,4-methylenedioxymethamphetamine (MDMA) as an adjunct in emotionally focused couples therapy (EFT) with clients in which at least one participant has endured a traumatic experience and reports symptoms of post-traumatic stress disorder (PTSD). Despite classification as a Schedule I drug on the Controlled Substances Act (CSA), in 2017 the U.S. Food and Drug Administration designated MDMA as a “breakthrough therapy” in the treatment of PTSD and approved plans for a Phase 3 clinical trial sponsored by the Multidisciplinary Association for Psychedelic Studies. This article aims to integrate previous and current research involving the therapeutic use of MDMA-assisted psychotherapy into the treatment of PTSD with the systemic, evidence-based approach of EFT.